Search research articles
Contact Us
Filters
Showing results (231-240 of 248) with videos related to
Page
of 25
Sort By:
The Prostate
|
November 15, 2023
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness
Channing J Paller, Pedro C Barata, Justin Lorentz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors
Atish D Choudhury, Celestia S Higano, Johann S de Bono, et al.
Scientific Reports
|
July 2, 2025
Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumors
J Abraham, V Domenyuk, N Perdigones, et al.
Cancer Research Communications
|
December 18, 2023
Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States
Emily M Rencsok, Natalie Slopen, Hannah D McManus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2022
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial
Phuoc T Tran, Kathryn Lowe, Hua-Ling Tsai, et al.
European Urology Open Science
|
December 22, 2021
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Karen A Autio, Emmanuel S Antonarakis, Tina M Mayer, et al.
JCO Precision Oncology
|
April 5, 2024
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations
Joseph J Park, Alec Chu, Jinju Li, et al.
Cancer
|
May 5, 2021
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer
Daniel J George, Susan Halabi, Elisabeth I Heath, et al.
Nature Cancer
|
November 5, 2021
Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer
Yuanyuan Qiao, Jae Eun Choi, Jean C Tien, et al.
JCO Oncology Practice
|
September 21, 2023
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial
Huma Q Rana, Jill E Stopfer, Michelle Weitz, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 248) with videos related to
Sort By:
Page
of 25
The Prostate
|
November 15, 2023
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness
Channing J Paller, Pedro C Barata, Justin Lorentz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors
Atish D Choudhury, Celestia S Higano, Johann S de Bono, et al.
Scientific Reports
|
July 2, 2025
Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumors
J Abraham, V Domenyuk, N Perdigones, et al.
Cancer Research Communications
|
December 18, 2023
Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States
Emily M Rencsok, Natalie Slopen, Hannah D McManus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2022
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial
Phuoc T Tran, Kathryn Lowe, Hua-Ling Tsai, et al.
European Urology Open Science
|
December 22, 2021
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Karen A Autio, Emmanuel S Antonarakis, Tina M Mayer, et al.
JCO Precision Oncology
|
April 5, 2024
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations
Joseph J Park, Alec Chu, Jinju Li, et al.
Cancer
|
May 5, 2021
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer
Daniel J George, Susan Halabi, Elisabeth I Heath, et al.
Nature Cancer
|
November 5, 2021
Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer
Yuanyuan Qiao, Jae Eun Choi, Jean C Tien, et al.
JCO Oncology Practice
|
September 21, 2023
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial
Huma Q Rana, Jill E Stopfer, Michelle Weitz, et al.
Page
of 25